Clara Mayo

4.0k total citations
30 papers, 839 citations indexed

About

Clara Mayo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Clara Mayo has authored 30 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Clara Mayo's work include Lung Cancer Treatments and Mutations (19 papers), Cancer Genomics and Diagnostics (9 papers) and Lung Cancer Research Studies (6 papers). Clara Mayo is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Cancer Genomics and Diagnostics (9 papers) and Lung Cancer Research Studies (6 papers). Clara Mayo collaborates with scholars based in Spain, United States and Switzerland. Clara Mayo's co-authors include Miguel Ángel Molina‐Vila, Rafael Rosell, Carlota Costa, Ana Giménez‐Capitán, Niki Karachaliou, Cristina Queralt, Rafael Rosell, Bartomeu Massutí, Miquel Tarón and Noemı́ Reguart and has published in prestigious journals such as Journal of Personality and Social Psychology, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Clara Mayo

29 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clara Mayo Spain 14 628 541 282 224 51 30 839
Shinsuke Hashida Japan 12 345 0.5× 332 0.6× 382 1.4× 225 1.0× 56 1.1× 30 719
Kentaro Iwanaga Japan 14 396 0.6× 373 0.7× 489 1.7× 241 1.1× 70 1.4× 24 864
Catherine B. Meador United States 11 338 0.5× 408 0.8× 352 1.2× 207 0.9× 49 1.0× 35 725
Rebekah A. Burich United States 13 452 0.7× 367 0.7× 262 0.9× 264 1.2× 108 2.1× 22 710
William Holland United States 15 260 0.4× 260 0.5× 258 0.9× 95 0.4× 44 0.9× 33 537
Imane Chaib Spain 14 358 0.6× 309 0.6× 428 1.5× 199 0.9× 79 1.5× 39 719
Bin-Chi Liao Taiwan 15 561 0.9× 553 1.0× 217 0.8× 118 0.5× 39 0.8× 36 791
J. Zugazagoitia Spain 3 375 0.6× 291 0.5× 225 0.8× 130 0.6× 44 0.9× 6 527
Annamaria Siggillino Italy 13 324 0.5× 256 0.5× 274 1.0× 138 0.6× 53 1.0× 24 514

Countries citing papers authored by Clara Mayo

Since Specialization
Citations

This map shows the geographic impact of Clara Mayo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Mayo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Mayo more than expected).

Fields of papers citing papers by Clara Mayo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Mayo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Mayo. The network helps show where Clara Mayo may publish in the future.

Co-authorship network of co-authors of Clara Mayo

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Mayo. A scholar is included among the top collaborators of Clara Mayo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Mayo. Clara Mayo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karachaliou, Niki, Daniela Morales-Espinosa, J. Garde, et al.. (2017). P2.06-010 AZD9291 as 1st-Line Therapy for EGFR Mutant NSCLC Patients with Concomitant Pretreatment EGFR T790M Mutation. The AZENT Study. Journal of Thoracic Oncology. 12(1). S1074–S1075. 1 indexed citations
2.
Anguera, Geòrgia, Miguel Ángel Molina‐Vila, Juan Ramón Gras-Cabrerizo, et al.. (2016). Molecular analysis in serial biopsies in sinonasal mucosal melanoma. Annals of Oncology. 27. vi346–vi346.
3.
Garzón, Mónica, Sergi Villatoro, Cristina Teixidó, et al.. (2016). KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients. Translational Lung Cancer Research. 5(5). 511–516. 16 indexed citations
4.
Benlloch, Susana, María Luisa Botero, Clara Mayo, et al.. (2014). Clinical Validation of a PCR Assay for the Detection of EGFR Mutations in Non–Small-Cell Lung Cancer: Retrospective Testing of Specimens from the EURTAC Trial. PLoS ONE. 9(2). e89518–e89518. 34 indexed citations
5.
Karachaliou, Niki, Carlota Costa, Ana Giménez‐Capitán, et al.. (2013). BRCA1, LMO4, and CtIP mRNA Expression in Erlotinib-Treated Non–Small-Cell Lung Cancer Patients with EGFR Mutations. Journal of Thoracic Oncology. 8(3). 295–300. 15 indexed citations
6.
Hübers, Annemarie, Daniëlle A.M. Heideman, Yasushi Yatabe, et al.. (2013). EGFR mutation analysis in sputum of lung cancer patients: A multitechnique study. Lung Cancer. 82(1). 38–43. 22 indexed citations
7.
Rosell, Rafael, Miguel Ángel Molina‐Vila, Miquel Tarón, et al.. (2012). EGFR compound mutants and survival on erlotinib in non-small cell lung cancer (NSCLC) patients (p) in the EURTAC study.. Journal of Clinical Oncology. 30(15_suppl). 7522–7522. 22 indexed citations
8.
Kaen, Diego, Rubén Dario Kowalyszyn, Marcela Carballido, et al.. (2012). F-box and WD repeat domain-containing 7 (FBXW7) mRNA and outcome in biliary tract cancer.. Journal of Clinical Oncology. 30(15_suppl). e14521–e14521. 1 indexed citations
9.
Karachaliou, Niki, Clara Mayo, Carlota Costa, et al.. (2012). KRAS Mutations in Lung Cancer. Clinical Lung Cancer. 14(3). 205–214. 173 indexed citations
10.
Gascó, Amaya, Miguel Ángel Molina‐Vila, Jordi Bertrán-Alamillo, et al.. (2012). Association of p53 mutations with progression-free survival (PFS) and overall survival (OS) in EGFR-mutated non-small cell lung cancer (NSCLC) patients (p) treated with erlotinib.. Journal of Clinical Oncology. 30(15_suppl). e18143–e18143. 3 indexed citations
11.
Santarpía, Mariacarmela, María Sanchez-Ronco, Carlota Costa, et al.. (2011). mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients. Journal of Translational Medicine. 9(1). 163–163. 22 indexed citations
12.
Porta, R., J.M. Sánchez-Torres, Luis Paz‐Ares, et al.. (2010). Brain metastases from lung cancer responding to erlotinib: the importance ofEGFRmutation. European Respiratory Journal. 37(3). 624–631. 247 indexed citations
13.
Simonetti, S., Miguel Ángel Molina‐Vila, Cristina Queralt, et al.. (2010). Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer. Journal of Translational Medicine. 8(1). 135–135. 76 indexed citations
14.
Mayo, Clara & Xavier Mayol. (2009). Cycling D1 negatively regulates the expression of differentiation genes in HT-29 M6 mucus-secreting colon cancer cells. Cancer Letters. 281(2). 183–187. 6 indexed citations
15.
Molina‐Vila, Miguel Ángel, Jordi Bertrán-Alamillo, Clara Mayo, & Rafael Rosell. (2009). Screening for EGFR mutations in lung cancer.. PubMed. 8(43). 181–4. 7 indexed citations
16.
Molina‐Vila, Miguel Ángel, Jordi Bertran-Alamillo, Noemı́ Reguart, et al.. (2008). A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells. Journal of Thoracic Oncology. 3(11). 1224–1235. 83 indexed citations
17.
Queralt, Cristina, Clara Mayo, Miguel Ángel Molina‐Vila, et al.. (2007). High correspondence between EGFR mutations in tissue and in circulating DNA form non-small-cell lung cancer (NSCLC) patients (p) with poor performance status (PS). Cancer Research. 67. 5676–5676. 1 indexed citations
18.
Mayo, Clara, Josep Lloreta, Francisco X. Real, & Xavier Mayol. (2007). In vitro differentiation of HT‐29 M6 mucus‐secreting colon cancer cells involves a trychostatin A and p27KIP1‐inducible transcriptional program of gene expression. Journal of Cellular Physiology. 212(1). 42–50. 14 indexed citations
19.
Anta, Josep Maria de, Clara Mayo, Françesc Solé, et al.. (2006). Methotrexate resistance in vitro is achieved by a dynamic selectionprocess of tumor cell variants emerging during treatment. International Journal of Cancer. 119(7). 1607–1615. 7 indexed citations
20.
LaFrance, Marianne & Clara Mayo. (1976). Racial differences in gaze behavior during conversations: Two systematic observational studies.. Journal of Personality and Social Psychology. 33(5). 547–552. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinsuke Hashida Breakdown of academic impact, for papers by Kentaro Iwanaga Breakdown of academic impact, for papers by Catherine B. Meador Breakdown of academic impact, for papers by Rebekah A. Burich Breakdown of academic impact, for papers by William Holland Breakdown of academic impact, for papers by Imane Chaib Breakdown of academic impact, for papers by Bin-Chi Liao Breakdown of academic impact, for papers by J. Zugazagoitia Breakdown of academic impact, for papers by Annamaria Siggillino
Rankless by CCL
2026